Skip to main content
Clinical Trials/NL-OMON30534
NL-OMON30534Not yet recruitingNot Applicable

Prospective cohort study on the effect of surgical treatment of obstructive sleep apnea syndrome on blood pressure (and other cardiovascular risk factors). - ESTOSASBP

Sint Lucas Andreas Ziekenhuis0 sites100 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Epsworth Sleepiness Scale (ESS) >9
  • Apnea Hypopnea Index(AHI) * 15

Exclusion Criteria

  • Patients with an AHI<15 or ESS<10 or who suffer from predominant central sleep apnea or have contraindications for surgery will be excluded. Patients in whom relevant cardiovascular medication (lipid lowering drugs, ACE-/AT-1-inhibitors, ß-blocking agents, diuretics, calcium antagonists, nitrates, oral anti-diabetics and insulin therapy) is altered or started during follow-up will be excluded. Patients in whom OSAS surgery was not successful will be excluded. Patients having a systolic blood pressure>180mm Hg, total cholesterol (TC)>8mmol/l, TC/HDL ratio>8 or an abnormal ECG will be consulted by a cardiologist.

Investigators

Sponsor
Sint Lucas Andreas Ziekenhuis

Similar Trials